Zatosetron maleate
Zatosetron has been identified as a potent, orally available, long-acting, selective 5HT3 receptor antagonist, which is potentially useful in the treatment of central nervous system disorders such as emesis induced by oncolytic drugs, migraine, dementia, anxiety, schizophrenia, and substance abuse.
| Catalog Number | 123482-23-5 |
| Alternative Name(s) | (Z)-but-2-enedioic acid;5-chloro-2,2-dimethyl-N-[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]-3H-1-benzofuran-7-carboxamide; 5-chloro-2,3-dihydro-2,2-dimethyl-N-(8-methyl-8-azabicyclo(3.2.1)oct-3-yl)-7-benzofurancarboxamide; LY 277359; LY 277359 maleate; LY-277359; zatosetron; zatosetron maleate |
| Molecular Formula | C23H29ClN2O6 |
| CAS# | 123482-23-5 |
| Inchi | 1S/C19H25ClN2O2.C4H4O4/c1-19(2)10-11-6-12(20)7-16(17(11)24-19)18(23)21-13-8-14-4-5-15(9-13)22(14)3;5-3(6)1-2-4(7)8/h6-7,13-15H,4-5,8-10H2,1-3H3,(H,21,23);1-2H,(H,5,6)(H,7,8)/b;2-1-/t13?,14-,15+; |
| Inchi Key | HAFQATMFFHYNPN-BSLJCGBVSA-N |
| Size | Please inquire |
| Supplier Page | https://www.bocsci.com/zatosetron-maleate-cas-123482-23-5-item-7621.html |